376 related articles for article (PubMed ID: 70922)
1. Intracellular distribution of dopa and 5-S-cysteinyldopa in Harding-Passey melanoma.
Agrup G; Falck B; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1977; 57(4):313-5. PubMed ID: 70922
[TBL] [Abstract][Full Text] [Related]
2. Characterization of structural properties for morphologic differentiation of melanosomes. III. free and protein-bound dopa and 5-S-cysteinyldopa in B16 and Harding-Passey melanomas.
Ito S; Homma K; Kiyota M; Fujita K; Jimbow K
J Invest Dermatol; 1983 Mar; 80(3):207-9. PubMed ID: 6402551
[TBL] [Abstract][Full Text] [Related]
3. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
[TBL] [Abstract][Full Text] [Related]
4. [Contents of cysteinyldopa isomers and DOPA in lesions of malignant melanoma (author's transl)].
Morishima T; Saito M; Fujita M; Fukada E; Nagashima N; Hanawa S
Nihon Hifuka Gakkai Zasshi; 1982 Feb; 92(2):157-9. PubMed ID: 6806514
[No Abstract] [Full Text] [Related]
5. Intracellular distribution of dopa and 5-S-cysteinyldopa in pigment cells with minimal pigment formation.
Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1979; 59(4):355-6. PubMed ID: 92151
[TBL] [Abstract][Full Text] [Related]
6. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
Morishima T; Tatsumi F; Fukada E; Saito M; Fujita M; Nagashima N; Hanawa S
Arch Dermatol Res; 1983; 275(2):76-9. PubMed ID: 6409012
[TBL] [Abstract][Full Text] [Related]
7. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
Agrup G; Hansson C; Rorsman H; Rosengren E
Acta Derm Venereol; 1980; 60(1):63-4. PubMed ID: 6153836
[TBL] [Abstract][Full Text] [Related]
8. Free and bound 5-S-cysteinyldopa and dopa in human malignant melanomas.
Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1978; 58(3):270-2. PubMed ID: 78645
[TBL] [Abstract][Full Text] [Related]
9. Determination of DOPA, dopamine, and 5-S-cysteinyl-DOPA in plasma, urine, and tissue samples by high-performance liquid chromatography with electrochemical detection.
Ito S; Kato T; Maruta K; Fujita K; Kurahashi T
J Chromatogr; 1984 Nov; 311(1):154-9. PubMed ID: 6440898
[No Abstract] [Full Text] [Related]
10. Distribution of 65Zn in mice with melanomas and in the subcellular fractions of melanomas.
Borovanský J; Hearn PR; Bleehen SS; Russell RG
Neoplasma; 1980; 27(3):247-52. PubMed ID: 7453844
[TBL] [Abstract][Full Text] [Related]
11. [Biochemical diagnoses of malignant melanomas with determinations of 5-S-cysteinyldopa in lesions].
Sameshima T; Morishima T
Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):665-72. PubMed ID: 2511358
[TBL] [Abstract][Full Text] [Related]
12. Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.
Jimbow K; Miyake Y; Homma K; Yasuda K; Izumi Y; Tsutsumi A; Ito S
Cancer Res; 1984 Mar; 44(3):1128-34. PubMed ID: 6318981
[TBL] [Abstract][Full Text] [Related]
13. [A newly established melanoma cell line (GAK) with 5-S-cysteinyldopa phenotype].
Nozawa S; Ohta H; Tsukazaki K; Udagawa Y; Kurihara S; Kano S
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jun; 36(6):883-92. PubMed ID: 6431036
[TBL] [Abstract][Full Text] [Related]
14. On the occurrence of cysteinyldopa and dopa in melanocytes and benign nevi cells.
Falck B; Jacobsson S; Lindvall O; Nietsche UB
Scand J Plast Reconstr Surg; 1976; 10(3):185-8. PubMed ID: 1053447
[TBL] [Abstract][Full Text] [Related]
15. gamma-Glutamyl transpeptidase, tyrosinase, and 5-S-cysteinyldopa production in melanoma cells.
Mojamdar M; Ichihashi M; Mishima Y
J Invest Dermatol; 1983 Aug; 81(2):119-21. PubMed ID: 6135733
[TBL] [Abstract][Full Text] [Related]
16. 5-S-cysteinyldopa in the urine of melanoma patients.
Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
[TBL] [Abstract][Full Text] [Related]
17. Dopa and 5-S-cysteinyldopa in the serum of albino, black, and red guinea pigs.
Hansson C; Agrup G; Rorsman H; Rosengren E
Acta Derm Venereol; 1980; 60(2):155-56. PubMed ID: 6155023
[TBL] [Abstract][Full Text] [Related]
18. 5-S-cysteinyldopa as a substrate for tyrosinase.
Hansson C; Rorsman H; Rosengren E
Acta Derm Venereol; 1980; 60(5):399-402. PubMed ID: 6162310
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of amelanotic malignant melanoma by means of the fluorescence method (Falck & Hillarp) and determination of 5-S-cysteinyldopa in the lesions].
Morishima T; Fukada E; Nagashima N
Nihon Hifuka Gakkai Zasshi; 1983 Jan; 93(1):51-4. PubMed ID: 6408288
[No Abstract] [Full Text] [Related]
20. Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis.
Agrup G; Agrup P; Andersson T; Falck B; Hansson J-A ; Jacobsson S; Rorsman H; Rosengrem A-M ; Rosengren E
Acta Derm Venereol; 1975; 55(5):337-41. PubMed ID: 52967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
